Actilyse Treatment Set Infusion
Alteplase (Recombinant Human Tissue-Type Plasminogen Activator)
50mg
Boehringer Ingelheim Pharma GmbH & Co. KG
| Pack size | 2 Vials (50mg) + 2 Solvent (50ml) + Kit |
|---|---|
| Dispensing mode | POM |
| Source | GERMANY |
| Agent | GULF DRUG EST. |
| Retail Price | 6134.00 AED |
Indications
Actilyse Treatment Set Infusion is used for:
For management of acute myocardial infarction, acute ischemic strok and for lysis of acute pulmonary emboli
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Alteplase (Recombinant Human Tissue-Type Plasminogen Activator) :
Mechanism of Action
Alteplase binds to fibrin rich clots via the fibronectin finger-like domain and the Kringle 2 domain. The protease domain then cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action.
Note
Actilyse Treatment Set 50mg Infusion manufactured by Boehringer Ingelheim Pharma GmbH & Co. KG. Its generic name is Alteplase (Recombinant Human Tissue-Type Plasminogen Activator). Actilyse Treatment Set is availble in United Arab Emirates.
Farmaco UAE drug index information on Actilyse Treatment Set Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.